Technical View
STI, Biosensors, SPH
Straits Times Index: Bottoming out?

| Significance |
Price |
Details |
| 2nd Resistance |
2,697 – 2,706 |
Technical gap |
| 1st Resistance |
2,605 – 2,622 |
Technical gap |
| Current level |
2,570.67 |
Closing price of FSSTI on 12 Sep 08 |
| Support level |
2,541 – 2,560 |
Daily low on 11 Sep / Lower Bollinger Band |
| Wave Count |
Start date |
End Date |
Start Value |
End Value |
| Wave A |
10 Oct 07 |
17 Mar 08 |
3,906 |
2,745 |
| Wave B |
17 Mar 08 |
05 May 08 |
2,745 |
3,269 |
| Wave C |
05 May 08 |
na |
3,269 |
na |
The technical bounce in the Straits Times Index (FSSTI Index) took place as we had expected although it eventually
gave up all of its gains to close 4 points lower to 2,570 for the previous week. Trading was highly volatile as it moved in
a 2,541 – 2,697 range as price action broke through our former resistance level at around 2,600, although it eventually
failed to take out the technical gap at the 2,700 area and ultimately fell below our previous 2,554 support mark.
We present an alternate Wave Count as opposed to the notion that the STI had bottomed out at 2,745. We believe that
the STI is currently riding on a Wave C, although it is highly debatable as to whether this Wave may have ended. As
Waves C usually travel the entire price length of Waves A, this is highly bearish for the STI as it would imply an eventual
price target of 2,106. However, we also note that the 61.8% extension of Wave A (the second most probable price
length of Wave C) equates to 2,552, a level which the STI is currently trading very close to.
Coupled with the shorter-term outlook with the immediate support at 2,541 – 2,560, we believe that a clear break below
this area would indeed signify that the STI is set to plunge to 2,106. On the other hand, should the 2,541 – 2,560
support level hold, this would indicate that Wave C has been completed and that the STI has bottomed out.
Biosensors: Rally to continue

| Significance |
Price |
Details |
| 2nd Resistance |
0.605 – 0.615 |
Technical gap |
| 1st Resistance |
0.550 – 0.555 |
21-day MA / Daily highs on 04, 09 and 12 Sep |
| Current level |
0.535 |
Closing price of BIG on 12 Sep 08 |
| 1st Support |
0.525 |
Daily lows on 09 and 10 Sep |
| 2nd Support |
0.495 – 0.505 |
Daily lows on 30 & 31 Jul, 01 Aug and 05 Sep |
We previously mentioned that the technical outlook for Biosensors (BIG SP) had turned bullish while the stock
eventually appreciated 2.9% during the previous week. At present, we believe that the technical picture is still positive,
given that price action is currently depicting a series of higher highs and lower lows which indicate that the uptrend is
still intact. Furthermore, the 14-day RSI remains far from hitting the overbought territory.
Prior to the support level at the 0.495 – 0.505 area which stays unchanged from our earlier report, we have identified
another layer of support at the 0.525 mark as defined by the daily lows on 09 and 10 Sep. Our respective resistance
levels also remain – as share price is currently within the vicinity of the 1st resistance area, we recommend an entry
point only after the barrier at 0.550 – 0.555 is broken.
SPH: Consolidation within 4.00 – 4.20
Significance

| Significance |
Price |
Details |
| Resistance level |
4.19 – 4.20 |
Upper Bollinger Band / 100-day MA / Daily highs on 08 and 10 Sep |
| Current level |
4.10 |
Closing price of SPH on 12 Sep 08 |
| Support level |
4.00 |
Lower Bollinger Band / Daily lows from 07 to 19 Aug |
After the bollinger bands had tightened for the most of mid-August, price action of Singapore Press Holdings (SPH SP)
then broke out and violated the upper band repeatedly as both the bands widened. Currently, the bollinger bands are
looking to tighten up again, indicating that a period of consolidation may be forthcoming. Additionally, the 14-day ADX
has also fallen below the 20 mark which implies that there is no prevailing trend. Lastly, the 14-day RSI is presently at
the mid-point of the overbought and oversold benchmark, further suggestive of a neutral inclination.
Share price should be confined to a 4.00 – 4.20 range. The resistance level is derived from the confluence of the upper
bollinger band, the 100-day moving average and a series of daily highs while the support level is identified by the lower
bollinger band and a series of daily lows.
DMG & Partners Research Guide to Investment Ratings
Buy: Share price may exceed 10% over the next 12 months
-----------------------------------------------------------------------------------------------------------------------------------------------
Trading Buy: Share price may exceed 15% over the next 3 months, however longer-term outlook remains uncertain
-----------------------------------------------------------------------------------------------------------------------------------------------
Neutral: Share price may fall within the range of +/- 10% over the next 12 months
-----------------------------------------------------------------------------------------------------------------------------------------------
Take Profit: Target price has been attained. Look to accumulate at lower levels
-----------------------------------------------------------------------------------------------------------------------------------------------
Sell: Share price may fall by more than 10% over the next 12 months
-----------------------------------------------------------------------------------------------------------------------------------------------
Not Rated: Stock is not within regular research coverage
This research is for general distribution. It does not have any regard to the specific investment objectives, financial situation and particular needs of
any specific recipient of this research report. You should independently evaluate particular investments and consult an independent financial adviser
before making any investments or entering into any transaction in relation to any securities or investment instruments mentioned in this report.
The information contained herein has been obtained from sources we believed to be reliable but we do not make any representation or warranty nor accept any responsibility or liability as to its accuracy, completeness or correctness. Opinions and views expressed in this report are subject to
change without notice.
This report does not constitute or form part of any offer or solicitation of any offer to buy or sell any securities, DMGAPS and its affiliates, their directors, connected person and employees may from time to time have interest and/or underwriting commitment in the securities mentioned in this
report.
DMG & Partners Securities Pte Ltd is a participant in the SGX-MAS Research Incentive Scheme and receives a compensation of S$5,000 per stock per annum covered under the Scheme.
DMG & Partners Securities Pte Ltd is a joint venture between OSK Securities Berhad (a subsidiary of OSK Investment Bank Berhad) and Deutsche Asia Pacific Holdings Pte Ltd (a subsidiary of Deutsche Bank Group). DMG & Partners Securities Pte Ltd is a Member of the Singapore Exchange Securities Trading Limited. |